14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
MNSO vs RLX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, RLX Technology Inc. (RLX) captures the overall head-to-head institutional edge over MINISO Group Holding Limited (MNSO) on higher Unified Composite conviction (40.1/100 SELL vs. 30.5/100 SELL) after splitting the core matrix 5–5 (led by Valuation Multiples), while MNSO wins 4–1 across the 6-pillar growth and valuation breakdown. MNSO trades at $12.12 (7.5x Forward P/E, 14.2% operating margin) versus RLX at $1.51 (6.7x Forward P/E, 13.1% operating margin).
Growth vs. Quality Trade-Off: RLX earns the overall head-to-head edge with a stronger Unified Composite Score (40.1/100 SELL vs. MNSO 30.5/100 SELL) and 0.44β · 26% Vol risk profile, whereas MNSO leads top-line expansion (+17.0% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although RLX compares more favorably head-to-head, both MNSO (30.5/100 SELL) and RLX (40.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: MNSO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 74.5); meanwhile RLX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MNSO vs RLX. Trailing 12-month operating profitability (MNSO 14.2% vs RLX 13.1%) and valuation multiples (MNSO 7.5x vs RLX 6.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Tobacco value chain with $1.9B market capitalization and 13.1% operating margin.
OpEx & R&D Reinvestment21.8% of Rev ($134M)
90D Engineering Disclosures0 Published
Investor FAQ MNSO vs RLX Key Questions & Quantitative Answers
As of Nov 17, 2026, RLX Technology Inc. (RLX) captures the overall head-to-head institutional edge over MINISO Group Holding Limited (MNSO) on higher Unified Composite conviction (40.1/100 SELL vs. 30.5/100 SELL) after splitting the core matrix 5–5 (led by Valuation Multiples), while MNSO wins 4–1 across the 6-pillar growth and valuation breakdown. MNSO trades at $12.12 (7.5x Forward P/E, 14.2% operating margin) versus RLX at $1.51 (6.7x Forward P/E, 13.1% operating margin). Growth vs. Quality Trade-Off: RLX earns the overall head-to-head edge with a stronger Unified Composite Score (40.1/100 SELL vs. MNSO 30.5/100 SELL) and 0.44β · 26% Vol risk profile, whereas MNSO leads top-line expansion (+17.0% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although RLX compares more favorably head-to-head, both MNSO (30.5/100 SELL) and RLX (40.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: MNSO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 74.5); meanwhile RLX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MNSO leads the Growth & Scale pillar: MNSO posts +17.0% YoY revenue growth and +200.0% YoY earnings growth on $3.22B TTM revenue (44.9% gross margin, 14.2% operating margin), compared with RLX at +15.5% YoY revenue growth and +0.6% YoY earnings growth on $615M TTM revenue (34.9% gross margin, 13.1% operating margin). On trailing 12-month operating scale, MNSO generates $3.22B in USD-normalized revenue versus $615M for RLX. In operating R&D and SG&A reinvestment, MNSO deploys 30.7% of Rev ($988M) (0 90-day corporate R&D disclosures) versus 21.8% of Rev ($134M) (0 disclosures) for RLX.
RLX screens cheaper on headline valuation multiples. MNSO trades at 7.5x Forward P/E, 19.0x Trailing P/E, N/M PEG, and 1.0x EV/Revenue (16.1% EBITDA margin), whereas RLX trades at 6.7x Forward P/E, 14.2x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (14.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MNSO (11.8% ROE) versus RLX (6.3% ROE) capital efficiency.
In options market volatility and institutional positioning, MNSO carries 30.6% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.31β · 42% Vol realized risk). By comparison, RLX carries 38.6% implied volatility (9th %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 26% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.